# The Pentagon is testing testosterone. A low number is not a diagnosis.

The Pentagon will test soldiers aged 30 and up for low testosterone every year. What the evidence says for and against it and why the split between temporary and true deficiency matters most for soldiers.

In U.S. Army Ranger School, testosterone in healthy young men drops by more than half, sometimes close to the level you see after castration. A few weeks later, with sleep and real food, it is back to normal. That single fact sits right in the middle of the debate coming out of Washington, because the Pentagon has decided to test its soldiers for low testosterone every year. Medically it is a smart idea and a delicate one, and the reason is exactly that swing in the numbers.

What did the Pentagon actually decide?

On July 15, 2026, Defense Secretary Pete Hegseth announced a new screening program. Active-duty and Reserve service members aged 30 and older will be tested for testosterone deficiency once a year. For those under 30 the test is optional. It gets folded into the yearly health check every soldier already does.

One point got lost in most headlines: only the test is mandatory, the treatment is not. A soldier with a low result can start testosterone replacement therapy (TRT, meaning testosterone given as a gel or injection), but nobody has to. Hegseth frames the goal as restoring natural capabilities rather than boosting performance artificially.

Why does service push testosterone down?

Military life reaches deep into the hormone system, and the evidence is solid. One week of five-hour nights lowered testosterone in young men by 10 to 15 percent in a University of Chicago study from 2011. Later work found the effect smaller, though the direction held.

Chronic stress adds to it. When the stress hormone cortisol stays high for long, it quiets the control center in the brain that tells the testes to produce. The biggest hit comes from hard physical load paired with too few calories, which is what the Ranger studies captured with drops of about 50 to 70 percent, and over 80 percent in the most extreme sustained-operations studies.

The key point is that these crashes are almost always temporary. In the studies the numbers returned to normal within two to six weeks of rest.

What speaks for the screening?

A real testosterone deficiency is treatable and often missed. Around 5.6 percent of men between 30 and 79 have low testosterone with symptoms, from fading libido and erection problems to muscle and bone loss, low drive and low mood.

In the right patients, therapy works. The best trial series so far, the Testosterone Trials, showed better sexual function (2016) plus stronger bones and improvement in mild anemia (both 2017) among men with confirmed deficiency. For years there was a fear that therapy raised heart-attack risk. The large TRAVERSE trial from 2023, with more than 5,000 men, eased that worry for properly targeted use.

There is also a practical case. Testosterone reference ranges are wide, and every man declines from his own peak, so an early personal reading helps make sense of later changes. Harvard urologist Abraham Morgentaler is among the supporters and calls a man's testosterone level one of the best single signals of his overall health.

What speaks against it?

The major medical societies advise against blanket testing of men without symptoms. The Endocrine Society, the leading hormone body, repeated this in a statement tied directly to the Pentagon news on July 16, 2026: there is not enough evidence for mass screening of men who have no symptoms. A low lab value on its own is simply not a disease.

A single test is also unreliable. Testosterone swings with time of day, meals, sleep and stress. In about 30 percent of men with a first low value, the second reading comes back normal, which is why guidelines ask for at least two morning blood draws plus symptoms before any diagnosis.

Therapy carries real downsides. Testosterone from outside quiets the body's own production. The testicles can shrink, sperm production drops, the blood thickens, and treatment often becomes a lifelong dependency. The same TRAVERSE trial that cleared the heart-attack concern also found more atrial fibrillation and more pulmonary embolism in the testosterone group. For young men who want children, the hit to fertility is the bigger worry.

The fixed age bothers many doctors too. Medicine diagnoses deficiency from symptoms, not from a birth year, and the roughly one percent yearly decline after 30 means almost nothing for a 30-year-old. Johns Hopkins endocrinologist Adrian Dobs called the approach crazy and pointed to measurement noise and fertility risk.

Then there is the marketing trap. The phrase low T took off after 2009 through television ads. An analysis in JAMA in 2017 showed that this advertising drove more testing and more prescriptions, often with no prior diagnosis. A state-ordered mass test could feed the same reflex of treating numbers instead of people.

The distinction that decides everything

The whole debate comes down to one split. An organic deficiency comes from lasting damage to the testes or pituitary gland and needs treatment, often for life. A functional deficiency comes from stress, poor sleep, excess weight or a calorie gap, and it usually lifts once the cause is gone.

The typical stressors of soldiering produce the functional kind. Here replacement therapy is usually the wrong tool, since the fix is removing the stressor rather than topping up the hormone. Guidelines even say plainly not to test during acute stress and to address reversible causes first. Urologist Helen Bernie puts it well: an abnormal result should lead to a careful medical work-up, not straight to a prescription.

Therapy or performance boost?

In the military the line between restoring and doping runs especially thin. Anabolic steroids are banned substances there, and testosterone is allowed only for a genuine deficiency. Hegseth stresses that the goal is bringing low levels back to normal. The distinction is medically sound and practically delicate, because high doses do measurably raise muscle strength. The Army's own research reaches a sober verdict: soldiers get the biggest performance gain from good training, rest and nutrition, not from the hormone.

And the politics?

Whether a man has a treatable hormone deficiency is not a question of left or right. It rests on symptoms, on lab values and on a clean diagnosis. Once a blood value becomes a symbol of manhood, the individual patient with real complaints slips out of view, and with him the thing good medicine actually looks at.

Whether this program becomes genuine prevention or a quick prescription will come down to an unglamorous detail: two morning blood draws instead of one, and a doctor's conversation that asks first about sleep, weight and stress.

---

_Canonical: https://longevity-cities.com/en/articles/when-the-pentagon-tests-soldiers-for-low-testosterone · Part of Longevity Cities · Updated 2026-07-18_